Islet amyloid polypeptide: Another key molecule in Alzheimer's pathogenesis?

Area of Science:

• Neuroscience
• Endocrinology
• Pathology

Background:

• Type 2 diabetes mellitus (T2DM) is increasingly associated with cognitive decline and Alzheimer's disease (AD).
• Shared pathological processes exist between T2DM and AD, but molecular links remain unclear.
• Human islet amyloid polypeptide (hIAPP), a T2DM hallmark, aggregates in the brain and correlates with cognitive impairment.

Purpose of the Study:

• To explore the potential role of hIAPP in the pathogenesis of Alzheimer's disease.
• To elucidate the molecular mechanisms connecting T2DM and AD through hIAPP.

Main Methods:

• Review of epidemiological evidence linking T2DM, cognitive decline, and AD.
• Analysis of shared biophysical and cytotoxic properties between hIAPP and amyloid-beta (Aβ).
• Discussion of potential hIAPP-mediated mechanisms in AD development.

Main Results:

• hIAPP aggregation is found in brain tissue of patients with T2DM and cognitive decline.
• hIAPP shares similarities with Aβ in properties and cytotoxic effects.
• hIAPP may contribute to AD pathogenesis through specific molecular pathways.

Conclusions:

• hIAPP is a potential key player in the development of Alzheimer's disease in diabetic patients.
• Understanding hIAPP's role can inform novel strategies for AD prevention and treatment in individuals with T2DM.
• Further research into hIAPP mechanisms is crucial for therapeutic advancements.